Canada’s Globalive offers $2.9 bln to buy Freedom Mobile – The Globe And Mail

Author of the article: Canadian investment firm Globalive Capital Inc has offered to buy Shaw Communications Inc’s wireless telecoms unit Freedom Mobile for C$3.75 billion ($2.94 billion) in cash, The Globe and Mail reported on Tuesday, citing a source. The report comes as Rogers Communications Inc seeks regulatory approval for its C$20 billion takeover deal…
Canada’s Globalive offers $2.9 bln to buy Freedom Mobile – The Globe And Mail

Author of the article:

Canadian investment firm Globalive Capital Inc has offered to buy Shaw Communications Inc’s wireless telecoms unit Freedom Mobile for C$3.75 billion ($2.94 billion) in cash, The Globe and Mail reported on Tuesday, citing a source.

The report comes as Rogers Communications Inc seeks regulatory approval for its C$20 billion takeover deal with Calgary-based Shaw, which was announced last March.

Earlier this month, Canada’s industry minister, François-Philippe Champagne, said he would not permit the wholesale transfer of Shaw’s wireless licenses to Rogers as part of a buyout bid for Shaw.

The all-cash offer to acquire Freedom Mobile’s wireless licenses, customer accounts, cellphone towers and stores was presented to Rogers last week, the report https://tgam.ca/3i8Xztt said.

Globalive, Freedom Mobile, Shaw and Rogers did not immediately respond to Reuters requests for comment.

The financing for the Freedom Mobile deal would be provided by a group of investors led by Twin Point Capital and Baupost Group, the report said. ($1 = 1.2770 Canadian dollars) (Reporting by Akriti Sharma in Bengaluru; Editing by Subhranshu Sahu)

Financial Post Top Stories

Sign up to receive the daily top stories from the Financial Post, a division of Postmedia Network Inc.

By clicking on the sign up button you consent to receive the above newsletter from Postmedia Network Inc. You may unsubscribe any time by clicking on the unsubscribe link at the bottom of our emails. Postmedia Network Inc. | 365 Bloor Street East, Toronto, Ontario, M4W 3L4 | 416-383-2300

Read More

Total
0
Shares
Leave a Reply

Your email address will not be published.

Related Posts
Medicenna Announces Management Change and Appoints Experienced Development Advisory Committee
Read More

Medicenna Announces Management Change and Appoints Experienced Development Advisory Committee

Phase 1/2 ABILITY study of MDNA11 remains on track for an update on additional safety pharmacokinetic (PK), and pharmacodynamic (PD) data in low-dose cohorts in Q1 2022 and initial efficacy results in mid-2022 Author of the article: TORONTO and HOUSTON, Jan. 17, 2022 (GLOBE NEWSWIRE) — Medicenna Therapeutics Corp. (“Medicenna” or “the Company”) (NASDAQ: MDNA…